Sibrowski W, Wüllenweber J
Institut für Transfusionsmedizin, Westfälische Wilhelms-Universität Münster.
Infusionsther Transfusionsmed. 1994 Aug;21 Suppl 1:60-3.
For some years, public interest has focused on transfusion-transmitted HIV. German blood donors are now selected and show only very low incidences in HIV and hepatitis. Only one per million donors seems to transmit HIV. The remaining risk of post-transfusion hepatitis is estimated to range between 1:10,000 and 1:100,000. Some new diagnostic tests might reduce the danger of transfusion-transmitted infections. Screening donors for anti-HBc is a well accepted tool to decrease post-transfusion hepatitis B. The HIV-p24-Ag test is expensive and only of doubtful value. Donor recruitment should be improved in future.
多年来，公众的关注焦点一直是输血传播的艾滋病毒。德国对献血者进行了筛选，艾滋病毒和肝炎的发病率非常低。每百万献血者中似乎只有一人会传播艾滋病毒。输血后肝炎的剩余风险估计在万分之一到十万分之一之间。一些新的诊断测试可能会降低输血传播感染的风险。筛查献血者的抗-HBc是一种被广泛接受的降低输血后乙型肝炎的方法。艾滋病毒p24抗原检测成本高昂，价值存疑。未来应改进献血者招募工作。
